-
Published 12/12/2025
Ferri GM, Martinez CB, Acevedo J, Bhatt S, Verma KP, Lee J, Abdallah M, Szalat RE, Sloan JM. Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors. Breast Cancer Res Treat. 2025 Dec 12; 215(1):36. PMID: 41385110.
-
Published 9/22/2025
Cetin O, Staron A, Teodorescu P, Sloan JM, Sanchorawala V, Szalat R. Bleeding Patterns and Clinical Outcomes in Patients With Systemic AL Amyloidosis-Related Acquired Factor X Deficiency. Am J Hematol. 2025 Dec; 100(12):2416-2420. PMID: 40981270.
-
Published 9/16/2025
Parekh A, Lerner A, Thomasson RR, Sloan JM. Incidence of Typical Neutrophil Count With Fy(a-b-) Status Among Hematology Referrals for Neutropenia at an Urban Safety-Net Hospital. Adv Hematol. 2025; 2025:2488148. PMID: 40994727.
-
Published 9/2/2025
Avila Rodriguez AM, Hu X, Varga C, Comenzo R, Sarosiek S, Sloan JM, Sanchorawala V, Doros G, Quillen K. Comparable peri-transplant mortality and incidence of febrile neutropenia after high-dose melphalan and autologous stem cell transplantation in patients with plasma cell dyscrasias treated as outpatient versus inpatient. Br J Haematol. 2025 Oct; 207(4):1679-1683. PMID: 40898649.
-
Published 6/3/2025
Dittus C, Weinstock MJ, Barnes J, Sandoval-Sus J, Grover NS, Beaven A, Hoye K, Shelton A, Tan X, Srinivasan MD, El-Jawahri A, Sarosiek S, Sloan JM. Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma. Br J Haematol. 2025 Jun 03. PMID: 40459047.